KR950704249A - 비타민 D 동족체의 신규 결정형(New crystalline from of a vitamin D analogue) - Google Patents

비타민 D 동족체의 신규 결정형(New crystalline from of a vitamin D analogue)

Info

Publication number
KR950704249A
KR950704249A KR1019950702271A KR19950702271A KR950704249A KR 950704249 A KR950704249 A KR 950704249A KR 1019950702271 A KR1019950702271 A KR 1019950702271A KR 19950702271 A KR19950702271 A KR 19950702271A KR 950704249 A KR950704249 A KR 950704249A
Authority
KR
South Korea
Prior art keywords
analogue
vitamin
new crystalline
pharmaceutical composition
calcipotriol
Prior art date
Application number
KR1019950702271A
Other languages
English (en)
Other versions
KR100309751B1 (ko
Inventor
토른가아르트 한젠 에릭
스미트 라스트룹 안데르젠 닐스
호프메이어 링보르그 레네
Original Assignee
에른스트 룬딩
레오 파마슈티칼 프로덕츠 리미티드 에이/에스(뢰벤스 케미스케 파브릭 프로둑티 온스 악티젤스캅)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10728784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR950704249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 에른스트 룬딩, 레오 파마슈티칼 프로덕츠 리미티드 에이/에스(뢰벤스 케미스케 파브릭 프로둑티 온스 악티젤스캅) filed Critical 에른스트 룬딩
Publication of KR950704249A publication Critical patent/KR950704249A/ko
Application granted granted Critical
Publication of KR100309751B1 publication Critical patent/KR100309751B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/02—Apparatus characterised by being constructed of material selected for its chemically-resistant properties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/321—Catalytic processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/327—Formation of non-aromatic carbon-to-carbon double bonds only
    • C07C5/333—Catalytic processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/32—Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by dehydrogenation with formation of free hydrogen
    • C07C5/327—Formation of non-aromatic carbon-to-carbon double bonds only
    • C07C5/333—Catalytic processes
    • C07C5/3335—Catalytic processes with metals
    • C07C5/3337—Catalytic processes with metals of the platinum group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/0204—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/0204—Apparatus characterised by their chemically-resistant properties comprising coatings on the surfaces in direct contact with the reactive components
    • B01J2219/0236—Metal based
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/02—Apparatus characterised by their chemically-resistant properties
    • B01J2219/025—Apparatus characterised by their chemically-resistant properties characterised by the construction materials of the reactor vessel proper
    • B01J2219/0277—Metal based
    • B01J2219/0286—Steel
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
    • C07C2523/42—Platinum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 우수한 기술적 특성과 우수한 안정성을 갖는 칼시포티리올 수화물―칼시포트리올의 신규 결정형에 관한 것이다.

Description

비타민 D 동족체의 신규 결정형(New crystalline from of a vitamin D analogue)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 칼시포트리올(1α, 3β, 5Z, 7E, 22E, 24S)―24―사이클로로프로필―9, 10―세코콜라―5,7,10(19),22―테트라엔―1,3,24―트리올)일수화물.
  2. 제1항에 따른 화합물을 함유하는 약제학적 조성물.
  3. 제2항에 있어서, 크림인 약제학적 조성물.
  4. 제2항에 있어서, 겔인 약제학적 조성물.
  5. 제2항 내지 제4항중 어느 한 항에 있어서, 활성 성분의 함량이 조성물 1g 당 1 내지 100㎍인 약제학적 조성물.
    ※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019950702271A 1993-01-15 1994-01-07 비타민d동족체의신규결정형 KR100309751B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939300763A GB9300763D0 (en) 1993-01-15 1993-01-15 Chemical compound
GB9300763.1 1993-01-15
PCT/DK1994/000011 WO1994015912A1 (en) 1993-01-15 1994-01-07 New crystalline form of a vitamin d analogue

Publications (2)

Publication Number Publication Date
KR950704249A true KR950704249A (ko) 1995-11-17
KR100309751B1 KR100309751B1 (ko) 2002-11-08

Family

ID=10728784

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702271A KR100309751B1 (ko) 1993-01-15 1994-01-07 비타민d동족체의신규결정형

Country Status (17)

Country Link
US (2) USRE39706E1 (ko)
EP (1) EP0679154B1 (ko)
JP (1) JP3729847B2 (ko)
KR (1) KR100309751B1 (ko)
CN (1) CN1040746C (ko)
AT (1) ATE159717T1 (ko)
AU (1) AU663249B2 (ko)
CA (1) CA2151730C (ko)
DE (1) DE69406529T2 (ko)
DK (1) DK0679154T3 (ko)
ES (1) ES2111287T3 (ko)
FI (1) FI108638B (ko)
GB (1) GB9300763D0 (ko)
GR (1) GR3025668T3 (ko)
NZ (1) NZ259679A (ko)
RU (1) RU2128646C1 (ko)
WO (1) WO1994015912A1 (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU710931B2 (en) * 1996-02-28 1999-09-30 Sumitomo Pharmaceuticals Company, Limited Crystalline vitamin D derivative
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
SI2915534T1 (sl) 1999-04-23 2018-10-30 Leo Pharma A/S Farmacevtski sestavek za dermalno uporabo za zdravljenje psoriaze, ki vsebuje vitamin D in kortikosteroid
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
AU2003291810A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
MY139521A (en) * 2004-03-18 2009-10-30 Leo Pharma As Stereoselective synthesis of vitamin d analogues
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
TWI318203B (en) * 2004-09-01 2009-12-11 Leo Pharma As Epimerization of allylic alcohols
PL2526930T3 (pl) * 2005-06-01 2014-05-30 Glaxosmithkline Ip Dev Ltd Formulacja witaminowa
EP1987023B1 (en) * 2006-02-10 2010-11-24 Amgen, Inc Hydrate forms of amg706
WO2007082533A1 (en) * 2006-03-17 2007-07-26 Leo Pharma A/S Isomerisation of pharmaceutical intermediates
WO2008027532A2 (en) * 2006-08-29 2008-03-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions including vitamin d and corticosteroid
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
CA2723540C (en) * 2008-05-08 2016-01-05 United Therapeutics Corporation Treprostinil monohydrate
WO2011002756A2 (en) * 2009-07-01 2011-01-06 Vitamin Derivatives, Inc. Vitamin d compounds and methods for preparing same
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
CN102770125B (zh) * 2009-12-22 2015-02-11 利奥制药有限公司 钙泊三醇一水化合物纳米晶体
JP5873439B2 (ja) 2009-12-22 2016-03-01 レオ ファーマ アクティーゼルスカブ ビタミンｄ類似体および溶媒と界面活性剤の混合物を含む皮膚組成物
NZ601001A (en) * 2009-12-22 2014-07-25 Leo Pharma As Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
NZ601002A (en) * 2009-12-22 2014-09-26 Leo Pharma As Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
RS53809B1 (en) 2010-06-11 2015-06-30 Leo Pharma A/S PHARMACEUTICAL COMPOSITION SKIN SPRAY CONTAINING VITAMIN D ANALYSIS AND CORTICOSTEROID
ES2736256T3 (es) 2011-03-14 2019-12-27 Drug Delivery Solutions Ltd Composición oftálmica
RU2602171C2 (ru) 2011-03-24 2016-11-10 Лео Фарма А/С Композиция, содержащая липидные наночастицы и кортикостероид или производное витамина d
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
CN103724162A (zh) * 2014-01-07 2014-04-16 成都医路康医学技术服务有限公司 一种银屑病治疗药物卡泊三醇溶剂化物的制备方法
MA41818A (fr) 2015-03-27 2018-01-30 Leo Pharma As Timbre à micro-aiguilles pour administration d'un principe actif à la peau
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457282A1 (fr) * 1979-05-23 1980-12-19 Roussel Uclaf Nouveau derive du 1a,25 dihydroxy cholecalciferol, son procede de preparation et son application comme medicament
JPS59104358A (ja) 1982-12-03 1984-06-16 Teijin Ltd １α，２４−ジヒドロキシコレカルシフエロ−ルの一水塩及びその製造法
EP0227826B1 (en) * 1985-08-02 1989-10-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii

Also Published As

Publication number Publication date
GR3025668T3 (en) 1998-03-31
NZ259679A (en) 1996-11-26
GB9300763D0 (en) 1993-03-03
JP3729847B2 (ja) 2005-12-21
CN1040746C (zh) 1998-11-18
USRE39706E1 (en) 2007-06-26
EP0679154A1 (en) 1995-11-02
JPH08505612A (ja) 1996-06-18
CN1115979A (zh) 1996-01-31
EP0679154B1 (en) 1997-10-29
ATE159717T1 (de) 1997-11-15
DK0679154T3 (da) 1998-03-30
AU663249B2 (en) 1995-09-28
FI108638B (fi) 2002-02-28
WO1994015912A1 (en) 1994-07-21
KR100309751B1 (ko) 2002-11-08
RU95116650A (ru) 1997-06-10
US5763426A (en) 1998-06-09
AU5857394A (en) 1994-08-15
DE69406529T2 (de) 1998-05-28
CA2151730A1 (en) 1994-07-21
RU2128646C1 (ru) 1999-04-10
FI952797A0 (fi) 1995-06-07
FI952797A (fi) 1995-06-07
DE69406529D1 (de) 1997-12-04
CA2151730C (en) 2005-01-04
ES2111287T3 (es) 1998-03-01

Similar Documents

Publication Publication Date Title
KR950704249A (ko) 비타민 D 동족체의 신규 결정형(New crystalline from of a vitamin D analogue)
KR890011837A (ko) 디데하이드로 비타민 d₃유도체
KR870006896A (ko) 서방성 약제학적 제제의 제조방법
AU7567787A (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
HUP0002547A2 (hu) Aktív D3-vitaminos emulziós borogatószerek
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
NO167578C (no) Gamma-cyklodekstrineter eller blandet gamma-cyklodekstrineterog framstilling derav.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
ES8503944A1 (es) Procedimiento para la obtencion de una nueva composicion farmaceutica, casi neutra, de aplicacion topica
KR940005278A (ko) 약제학적 조성물
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
BR9712807A (pt) ésteres de álcool complexos de alta-viscosidade
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
ATE45347T1 (de) Vitamin d3-derivate.
KR970074763A (ko) 불소화된 비타민 d₃ 유사체
AR003107A1 (es) Derivados de vitamina d para uso dermatologico, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichos derivados.
AU7675896A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
KR950000027A (ko) 농약 조성물
MX9303970A (es) COMPUESTOS ESTEROIDALES DE ANILLO A DE 17Ó Y 17ß-ALQUILCETONA-3-CARBOXIAROMATICO.
AU7291296A (en) Lipid alcohols as new immunosuppressive and antiviral drugs
KR940018351A (ko) 노나테트라에노산 유도체
KR870700071A (ko) 비타민 d 유도체 및 이의 제조방법
KR900005955A (ko) 페이스트상 치아 연마 조성물
AU7538494A (en) Stable composition containing wheat sprout juice and process for producing it
KR920017638A (ko) 농약 중독 예방용 피부 보호제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120824

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20130827

Year of fee payment: 13

EXPY Expiration of term